Ironwood Pharmaceuticals (IRWD) Other Non Operating Income (2011 - 2026)

Ironwood Pharmaceuticals (IRWD) has 12 years of Other Non Operating Income data on file, last reported at $42000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non Operating Income rose 13.51% year-over-year to $42000.0; the trailing twelve-month figure through Mar 2026 stood at $198000.0 (up 435.14% YoY), and the FY2025 full-year result was $193000.0, down 69.84% from the prior year.
• Other Non Operating Income declined to $42000.0 in Q1 2026, from $77000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $730000.0 in Q1 2022 to a low of -$681000.0 in Q2 2022.
• A 4-year average of $50600.0 and a median of $41000.0 in 2025 frame the typical range for Other Non Operating Income.
• Across the five-year window, Other Non Operating Income soared 103.77% in 2022 and sank 97.4% in 2023, its largest moves.
• Tracing IRWD's Other Non Operating Income over 4 years: stood at $52000.0 in 2022, then plunged by 63.46% to $19000.0 in 2023, then surged by 305.26% to $77000.0 in 2025, then slumped by 45.45% to $42000.0 in 2026.
• Business Quant data shows IRWD's Other Non Operating Income at $42000.0 in Q1 2026, $77000.0 in Q4 2025, and $40000.0 in Q3 2025.